Micro- and nanotechnology approaches for capturing circulating tumor cells

Cancer Nanotechnology

Volumn 1, Issue 1-6, 2010, Pages 3-11

  Panchapakesan, Balaji ^a   Caprara, Robert ^a   Velasco, Vanessa ^a   Loomis, James ^a   King, Ben ^a   Xu, Peng ^a   Burkhead, Tom ^a   Sethu, Palaniappan ^a   Stallons, L Jay ^b   McGregor, W Glenn ^b   Rai, Shesh N ^c   Kloecker, Goetz ^d   Wickstrom, Eric ^e  

^a University of Louisville   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LOUISVILLE   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; TUMOR MARKER;

ANALYTICAL EQUIPMENT; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CIRCULATING TUMOR CELL; HUMAN; IMMUNOASSAY; MICROTECHNOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR IMAGING; NANOANALYSIS; NANOCHIP; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR CELL;

EID: 79952650661     PISSN: 18686958     EISSN: 18686966     Source Type: Journal    
DOI: 10.1007/s12645-010-0007-z     Document Type: Review

References (62)

1. Ashworth TR (1869) A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust Med J 14:146-147
2. Baker MK, Mikhitarian K, Osta W, Callahan K, Hoda R, Brescia F, Kneuper-Hall R, Mitas M, Cole DJ, Gillanders WE (2003) Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real- time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res 9(13):4865-4871
3. Braun S, Naume B (2005) Circulating and disseminated tumor cells. J Clin Oncol 23:1623-1626
4. Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793-802
5. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83:636
6. Candar Z, Ritchie AC, Hopkirk JF, Long RC (1962) The prognostic value of circulating tumor cells in patients with breast cancer. Surg Gynecol Obstet 115:291-294
7. Chao TI, Xiang S, Chen CS, Chin WC, Nelson AJ, Wang C, Lu J (2009) Carbon nanotubes promote neuron differentiation from human embryonic stem cells. Biophys Biochem Res Commun 384(4): 426-430
8. Colombo C, Rolfo F, Maggi G (1959) Further research on isolation of tumor cells from circulating blood. Minerva Med 50: 2217-2223
9. Cristofanilli M, Budd T, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791
10. Deng G, Herrler M, Burgess D, Manna E, Krag D, Burke JF (2008) Enrichment with anti-cytokeratin alone or combined with anti- EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients. Breast Cancer Res 10(4):
11. Dharmasiri U, Balamurugan S, Adams AA, Okagbare PI, Obubuafo A, Soper SA (2009) Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate specific membrane antigen aptamers immobilized to a polymeric microfluidic device. Electrophoresis 30: 3289-3300
12. Fan YW, Cui FZ, Hou SP, Xu QY, Chen LN, Lee IS (2002) Culture of neural cells on silicon wafers with nanoscale topographs. J Neurosci Meth 120(1): 17-23
13. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3): 161-171
14. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP (2009) In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumor cells. Nat Nanotechnol 4: 855-860
15. Gerges N, Rak J, Jabado N (2010) New technologies for the detection of circulating tumor cells. Br Med Bull 94: 49-64
16. Graeber F (1961) Methodology of cytological cancer diagnosis, especially demonstration of tumor cells in circulating blood of man. Verh Dtsch Ges Pathol 45: 264-266
17. Hasokawa M, Hayata T, Fukuda Y, Arakaki A, Yoshino T, Tanaka T, Matsunaga T (2010) Size selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal Chem 82: 6629-6635
18. He W, Wang H, Hartmann LC et al (2007) In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc Natl Acad Sci USA 104: 11760-11765
19. Hermanek P, Sobin LH, Wittekind C (1999) How to improve the present TNM staging system. Cancer 86: 2189-2191
20. Hirsch LR, Gobin AM, Lowery AR, Tam F, Drezek RA, Halas NJ, West JL (2006) Metal nanoshells. Ann Biomed Eng 34(1): 15-22
21. Jacob K, Sollier C, Jabado N (2007) Circulating tumor cells: detection, molecular profiling and future prospects. Expert Rev Proteomics 4: 741-756
22. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A (2004) Breast Cancer Res Treat 86:237
23. Kaiser J (2010) Cancer's circulation problem. Science 327: 1072-1074
24. Kam NW, O'Connell M, Wisdom JA, Dai H (2005) Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 102(33): 11600-11605
25. Khan SP, Auner GG, Newaz GM (2005) Influence of nanoscale surface roughness on neuronal attachment on silicon. Nanomedicine 1 (2): 125-129
26. Kim M-Y, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH-F, Norton L, Massagué J (2009) Tumor self-seeding by circulating cancer cells. Cell 139(7): 1315-1326
27. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63: 8122-8125
28. Kriparamanan R, Aswath P, Zhou A, Tang L, Nguyen KT (2006) Nanotopography: cellular responses to nanoscale materials. J Nanosci Nanotechnol 6(7): 1905-1919
29. Krivacic RT, Ladanyi A, Curry DN et al (2004) A rare-cell detector for cancer. Proc Natl Acad Sci USA 101: 10501-10504
30. Lara O, Tong XD, Zborowski M, Chalmers JJ (2004) Exp Hematol 32:891
31. Marx J (2007) Cancer's perpetual source. Science 24: 1029-1034
32. Mocellin S, Keilholz U, Rossi CR et al (2006) Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med 12: 130-139
33. Mostert B, Sleijfer S, Foekens JA et al (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35: 463-474
34. Nagrath S, Sesquist LV, Maheshwaran S, Bell DW, Irima D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M (2007) Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature 450: 1235-1241
35. Nam JM, Mirkin CA (2004) Bio-barcode-based DNA detection with PCR-like sensitivity. J Am Chem Soc 126: 5932-5933
36. Neuwalt EA et al (2004) Imaging of iron oxide nanoparticles with MR and light microscopy in patients with malignant brain tumors. Neuropathol Appl Neurobiol 5: 456-471
37. Panchapakesan B, Lu S, Sivakumar K, Teker K, Cesarone G, Wickstrom E (2005) Single wall carbon nanotube nanobomb agents for killing breast cancer cells. Nanobiotechnology 1:133
38. Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4(6): 448-456
39. Park JW (2002) Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 4: 95-99
40. Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204
41. Pierga JY, Bonneton C, Vincent-Salomon A et al (2004) Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients. Clin Cancer Res 10: 1392-1400
42. Pinzani P, Salvadori B, Simi L, Bianchi S, Distante V, Cataliotti L, Pazzagli M, Orlando C (2006) Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. Hum Pathol 37(6): 711-718
43. Rohmsdahl MM, Potter JF, Malmgren RA, Chu EW, Brindley CO, Smith RR (1960) A clinical study of circulating tumor cells in malignant melanoma. Surg Gynecol Obstet 111: 675-681
44. Rohmsdahl MM, Chu EW, Hume R, Smith RR (1961) The time of metastasis and release of circulating tumor cells as determined in an experimental system. Cancer 14: 883-888
45. Saito H (1961) Studies of cancer cells in circulating blood: experimental study on the fate of intraportally injected tumor cells and metastasis formation. Acta Med Biol Niigata 9:151-173
46. Shao N, Lu S, Wickstrom E, Panchapakesan B (2007) Integrated molecular targeting of IGF1R and Her2 surface receptors and destruction of breast cancer cells using carbon nanotubes. Nanotechnology 18:315101
47. Shao N, Wickstrom E, Panchapakesan B (2008) Nanotube antibody biosensor arrays for the detection of circulating breast cancer cells. Nanotechnology 19:465101
48. Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB (1993) New strategies in marrow purging for breast cancer patients receiving high-dose therapy with autologous bone marrow transplantation. Breast Cancer Res Treat 26: 19-23
49. Singletary SE, Greene FL (2003) Revision of breast cancer staging: the 6th edition of the TNM Classification. Semin Surg Oncol 21: 53-59
50. Singletary SE, Greene FL, Sobin LH (2003) Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 98: 2740-2741
51. Slade MJ, Coombes RC (2007) The clinical significance of disseminated tumor cells in breast cancer. Nat Clin Pract Oncol 4: 30-41
52. Soost HJ (1960) On the incidence of tumor cells in circulating blood. Dtsch Med Wochenschr 85: 893-899
53. Spall EJ, Jones RB (1994) Release of tumor cells from bone marrow. Blood 83 No. 3
54. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C, Paterlini-Brechot P (2000) Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 156 (1): 57-63
55. Vona G, Beroud C, Benachi A, Quenette A, Bonnefont JP, Romana S, Dumez Y, Lacour B, Paterlini-Brechot P (2002) Enrichment immunomorphological, and genetic characterization of fetal cells circulating in maternal blood. Am J Pathol 160(1): 51-58
56. Vona G, Estepa L, Beroud C, Damotte D, Capron F, Nalpas B, Mineur A, Franco D, Lacour B, Pol S, Brechot C, Paterlini-Brechot P (2004) Impact of cytomorphological detection of circulating tumor cells in patients with liver cancer. Hepatology 39(3):792-797
57. Wang S, Wang H, Jiao J, Chen KJ, Owens GE, Kamei K, Sun J, Sherman DJ, Behrenbruch CP, Wu H, Tseng HR (2009) Three dimensional nanostructured substrates towards efficient capture of circulating tumor cells. Angew Chem Int Ed Engl 48 (47): 8970-8973
58. Weiss L, Geduldig U (1991) Barrier cells: stromal regulation of hematopoiesis and blood cell release in normal and stressed murine bone marrow. Blood 78:975
59. Wilson JK (1959) The detection of tumor cells in circulating blood. Bull Tulane Univ Med Fac 18: 171-182
60. Wuest G, Birk G (1962) Demonstration and incidence of tumor cells in circulating human blood. Med Welt 17: 922-928
61. Zheng S, Lin H, Liu JQ, Balic M, Datar R, Cote RJ, Tai YC (2007) Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J Chromatogr A 1162: 154-161
62. Zieglschmid V, Hollmann C, Gutierrez B et al (2005) Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res 25:1803-1810